Laboratory Reagents

This tender concerns the procurement of various laboratory reagents, primarily for in-vitro diagnostics (IVD) and biochemical analysis. The specified items include reagents for determining total protein (biuret method), urea (urease/GLDH method), creatinine (Jaffe method), ALT and AST (IFCC methods), albumin, alpha-amylase (CNP-G3 method), uric acid (TBHBA enzymatic colorimetric method), glucose (GOD-PAP method), and total bilirubin (DCA method). These reagents are supplied in various volumes, typically in 5x50 ml or 5x100 ml configurations, totaling 250 ml or 500 ml respectively. The procurement falls under the CPV codes 33690000-3 (Medicinal and related products) and specifically 33696500-0 (Laboratory reagents). The tender aims to ensure the availability of essential diagnostic chemicals for laboratory testing, likely within a healthcare or research setting. The quantities and specific formulations indicate a need for routine laboratory operations, supporting clinical diagnostics and potentially research activities. The tender emphasizes the supply of high-quality reagents suitable for enzymatic spectrophotometry and other standard laboratory analytical techniques. The listed items are crucial for monitoring various physiological parameters and diagnosing medical conditions.

This is a supplies contract in the health and medical services sector, with a focus on Laboratory and Medical Equipment. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 197,000.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.